TY - JOUR
KW - buprenorphine
KW - Office-based opioid treatment
KW - opioid dependence
KW - Psychiatry residents
AU - J. Suzuki
AU - T. V. Ellison
AU - H. S. Connery
AU - C. Surber
AU - J. A. Renner
A1 - 
AB - OBJECTIVE: Psychiatrists are well suited to provide office-based opioid treatment (OBOT), but the extent to which psychiatry residents are exposed to buprenorphine training and OBOT during residency remains unknown. METHODS: Psychiatry residency programs in the USA were recruited to complete a survey. RESULTS: Forty-one programs were included in the analysis for a response rate of 23.7 %. In total, 75.6 % of the programs currently offered buprenorphine waiver training and 78.1 % provided opportunities to treat opioid dependence with buprenorphine under supervision. Programs generally not only reported favorable beliefs about OBOT and buprenorphine waiver training but also reported numerous barriers. CONCLUSIONS: The majority of psychiatry residency training programs responding to this survey offer buprenorphine waiver training and opportunities to treat opioid-dependent patients, but numerous barriers continue to be cited. More research is needed to understand the role residency training plays in impacting future practice of psychiatrists.
BT - Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry
C5 - Opioids & Substance Use; Education & Workforce
CP - 3
CY - United States
DO - 10.1007/s40596-015-0313-1
IS - 3
JF - Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry
N2 - OBJECTIVE: Psychiatrists are well suited to provide office-based opioid treatment (OBOT), but the extent to which psychiatry residents are exposed to buprenorphine training and OBOT during residency remains unknown. METHODS: Psychiatry residency programs in the USA were recruited to complete a survey. RESULTS: Forty-one programs were included in the analysis for a response rate of 23.7 %. In total, 75.6 % of the programs currently offered buprenorphine waiver training and 78.1 % provided opportunities to treat opioid dependence with buprenorphine under supervision. Programs generally not only reported favorable beliefs about OBOT and buprenorphine waiver training but also reported numerous barriers. CONCLUSIONS: The majority of psychiatry residency training programs responding to this survey offer buprenorphine waiver training and opportunities to treat opioid-dependent patients, but numerous barriers continue to be cited. More research is needed to understand the role residency training plays in impacting future practice of psychiatrists.
PP - United States
PY - 2016
SN - 1545-7230; 1042-9670
SP - 498
EP - 502
EP - 
T1 - Training in Buprenorphine and Office-Based Opioid Treatment: A Survey of Psychiatry Residency Training Programs
T2 - Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry
TI - Training in Buprenorphine and Office-Based Opioid Treatment: A Survey of Psychiatry Residency Training Programs
U1 - Opioids & Substance Use; Education & Workforce
U2 - 26017618
U3 - 10.1007/s40596-015-0313-1
VL - 40
VO - 1545-7230; 1042-9670
Y1 - 2016
ER -